Antibody-dependent cellular cytotoxicity (ADCC) function of peripheral blood polymorphonuclear neutrophils (PMN) after autologous bone marrow transplantation (ABMT)ERICSON, S. G; GUYRE, C. A; BENOIT, N. E et al.Bone marrow transplantation (Basingstoke). 1995, Vol 16, Num 6, pp 787-791, issn 0268-3369Article

Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation : a phase I pharmacokinetic and pharmacodynamic studyWOLFF, S. N; HERZIG, R; FAY, J et al.Bone marrow transplantation (Basingstoke). 2001, Vol 27, Num 3, pp 261-268, issn 0268-3369Article

The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unitCRAIG, M; CUMPSTON, A. D; HOBBS, G. R et al.Bone marrow transplantation (Basingstoke). 2007, Vol 39, Num 8, pp 477-482, issn 0268-3369, 6 p.Article

Thiotepa and fractionated TBI conditioning prior to allogeneic stem cell transplantation for advanced hematologic malignancies: a phase II single institution trialDEVETTEN, M. P; QAZILBASH, M. H; BEALL, C. L et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 7, pp 577-580, issn 0268-3369, 4 p.Article

Engraftment of leukocyte subsets following autologous bone marrow transplantation in acute myeloid leukemia using anti-myeloid (CD14 and CD15) monoclonal antibody-purged bone marrowERICSON, S. G; COLBY, E; WELCH, L et al.Bone marrow transplantation (Basingstoke). 1992, Vol 9, Num 2, pp 129-137, issn 0268-3369Article